Literature DB >> 21792749

Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients.

Sönke Weissenborn1, Rachel E Neale, Tim Waterboer, Damiano Abeni, Jan Nico Bouwes Bavinck, Adele C Green, Catherine A Harwood, Sylvie Euvrard, Mariet C W Feltkamp, Maurits N C de Koning, Luigi Naldi, Wim G V Quint, Gianpaolo Tessari, Charlotte M Proby, Ulrike Wieland, Herbert Pfister.   

Abstract

There is increasing evidence of an association between human papillomaviruses (HPV) of the beta-genus (beta-PV) and the development of cutaneous squamous cell carcinoma (SCC). The viral DNA load may be an important determinant of pathogenicity, but there are currently no baseline epidemiological data relating to load in people without SCC. We investigated DNA-loads of eight beta-PV types previously associated with risk of SCC. We collected eyebrow hairs from immunocompetent people (ICP) and organ transplant recipients (OTR), determined load by quantitative PCR and obtained demographic, phenotypic, and sun exposure information. Viral loads for ICP from Australia (n = 241) and Italy (n = 223) and OTR from across Europe (n = 318) spanned seven orders of magnitude. The median loads for all types were below one viral DNA copy per 60 cells and were highest for HPV5, HPV8 and HPV20. None of the populations had consistently higher viral loads for all 8 types. However, a higher proportion of OTR were in the top deciles of viral load distributions for six of the eight beta-PV types examined. In a nested analysis of Italian OTR and ICP, this finding was significant for six beta-PV types and cumulative load. Increasing age was significantly associated with higher viral loads in Australia, and there was a weak trend for higher loads with the time elapsed since transplantation in the OTR. We observed a wide distribution of beta-PV loads with OTR significantly more likely to have the highest viral loads. Thus, viral loads may be an important contributor to the higher risk of SCC in OTR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21792749     DOI: 10.1007/s00430-011-0212-3

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  34 in total

1.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  Quantification of beta-human papillomavirus DNA by real-time PCR.

Authors:  Sönke J Weissenborn; Ulrike Wieland; Monika Junk; Herbert Pfister
Journal:  Nat Protoc       Date:  2010-01       Impact factor: 13.491

3.  Relation between smoking and skin cancer.

Authors:  C A Wensveen; M T Bastiaens; C J Kielich; M J Berkhout; R G Westendorp; B J Vermeer; J N Bouwes Bavinck
Journal:  J Clin Oncol       Date:  2001-01-01       Impact factor: 44.544

4.  Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers.

Authors:  I L Boxman; R J Berkhout; L H Mulder; M C Wolkers; J N Bouwes Bavinck; B J Vermeer; J ter Schegget
Journal:  J Invest Dermatol       Date:  1997-05       Impact factor: 8.551

5.  The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice.

Authors:  Regina Pfefferle; Gian Paolo Marcuzzi; Baki Akgül; Hans Udo Kasper; Falko Schulze; Ingo Haase; Claudia Wickenhauser; Herbert Pfister
Journal:  J Invest Dermatol       Date:  2008-04-10       Impact factor: 8.551

6.  Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma.

Authors:  Maurits N C de Koning; Sönke Jan Weissenborn; Damiano Abeni; Jan Nico Bouwes Bavinck; Sylvie Euvrard; Adele C Green; Catherine A Harwood; Luigi Naldi; Rachel Neale; Ingo Nindl; Charlotte M Proby; Wim G V Quint; Francesca Sampogna; Jan Ter Schegget; Linda Struijk; Ulrike Wieland; Herbert J Pfister; Mariet C W Feltkamp
Journal:  J Gen Virol       Date:  2009-03-25       Impact factor: 3.891

7.  Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated.

Authors:  S J Weissenborn; A M Funke; M Hellmich; P Mallmann; P G Fuchs; H J Pfister; U Wieland
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

8.  General acquisition of human papillomavirus infections of skin occurs in early infancy.

Authors:  Annika Antonsson; Silvana Karanfilovska; Pelle G Lindqvist; Bengt Göran Hansson
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

9.  Betapapillomaviruses frequently persist in the skin of healthy individuals.

Authors:  Maurits N C de Koning; Linda Struijk; Jan Nico Bouwes Bavinck; Bernhard Kleter; Jan ter Schegget; Wim G V Quint; Mariet C W Feltkamp
Journal:  J Gen Virol       Date:  2007-05       Impact factor: 3.891

10.  Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy.

Authors:  Jan N Bouwes Bavinck; Sylvie Euvrard; Luigi Naldi; Ingo Nindl; Charlotte M Proby; Rachel Neale; Damiano Abeni; Gian P Tessari; Mariet C W Feltkamp; Alain Claudy; Eggert Stockfleth; Catherine A Harwood
Journal:  J Invest Dermatol       Date:  2007-03-22       Impact factor: 8.551

View more
  18 in total

Review 1.  Beta genus papillomaviruses and skin cancer.

Authors:  Peter M Howley; Herbert J Pfister
Journal:  Virology       Date:  2015-02-24       Impact factor: 3.616

Review 2.  Effects of β-HPV on DNA damage response pathways to drive carcinogenesis: a review.

Authors:  Danyal Tahseen; Peter L Rady; Stephen K Tyring
Journal:  Virus Genes       Date:  2021-01-03       Impact factor: 2.332

3.  Tumor prevention in HPV8 transgenic mice by HPV8-E6 DNA vaccination.

Authors:  Gian Paolo Marcuzzi; Sabine Awerkiew; Martin Hufbauer; Lysann Schädlich; Lutz Gissmann; Sabine Eming; Herbert Pfister
Journal:  Med Microbiol Immunol       Date:  2014-01-21       Impact factor: 3.402

Review 4.  [HPV-associated carcinomas of the female genital tract. Molecular mechanisms of development].

Authors:  M Reuschenbach; S Vinokurova; M von Knebel Doeberitz
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

5.  Cervical Infection with Cutaneous Beta and Mucosal Alpha Papillomaviruses.

Authors:  Laura Sichero; Mariam El-Zein; Emily M Nunes; Silvaneide Ferreira; Eduardo L Franco; Luisa L Villa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-04-04       Impact factor: 4.254

6.  Association between betapapillomavirus seropositivity and keratinocyte carcinoma-prospects for prophylactic vaccination?

Authors:  Herbert Pfister
Journal:  J Invest Dermatol       Date:  2015-05       Impact factor: 8.551

7.  Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma.

Authors:  Michelle R Iannacone; Tarik Gheit; Herbert Pfister; Anna R Giuliano; Jane L Messina; Neil A Fenske; Basil S Cherpelis; Vernon K Sondak; Richard G Roetzheim; Steffi Silling; Michael Pawlita; Massimo Tommasino; Dana E Rollison
Journal:  Int J Cancer       Date:  2013-11-12       Impact factor: 7.396

8.  Characterization of human papillomavirus type 154 and tissue tropism of gammapapillomaviruses.

Authors:  Agustín Enrique Ure; Ola Forslund
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

9.  Eyebrow hairs from actinic keratosis patients harbor the highest number of cutaneous human papillomaviruses.

Authors:  Ines Schneider; Mandy D Lehmann; Vlada Kogosov; Eggert Stockfleth; Ingo Nindl
Journal:  BMC Infect Dis       Date:  2013-04-24       Impact factor: 3.090

10.  Strain-specific properties and T cells regulate the susceptibility to papilloma induction by Mus musculus papillomavirus 1.

Authors:  Alessandra Handisurya; Patricia M Day; Cynthia D Thompson; Michael Bonelli; Douglas R Lowy; John T Schiller
Journal:  PLoS Pathog       Date:  2014-08-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.